Noked Capital LTD Gamida Cell Ltd. Transaction History

Noked Capital LTD

  • $946 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 18, 2020
SELL
$4.01 - $5.25 $219,066 - $286,807
-54,630 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$3.0 - $5.09 $447,354 - $759,010
-149,118 Reduced 73.19%
54,630 $237,000
Q2 2019

Aug 15, 2019
BUY
$4.98 - $11.32 $1.01 Million - $2.31 Million
203,748 New
203,748 $1.04 Million

Others Institutions Holding GMDA

# of Institutions
1
Shares Held
2.2K
Call Options Held
0
Put Options Held
0
View Full List

About Gamida Cell Ltd.

GMDA Quotes by TradingView
  • Ticker GMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,319,600
  • Market Cap $2.29M
  • Description
  • Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...
More about GMDA
Track This Portfolio

Track Noked Capital LTD Portfolio

Follow Noked Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Noked Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Noked Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email